Real-world evidence: breaking boundaries in rare diseaseThe COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have Share XReal-world evidence: breaking boundaries in rare diseasehttps://pharmaphorum.com/partner-content/real-world-evidence-breaking-boundaries-in-rare-disease/
A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
True patient-focused research through decentralised and hybrid trialsHow can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector Share XTrue patient-focused research through decentralised and hybrid trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/true-patient-focused-research-through-decentralised-and-hybrid-trials/
Pharma’s digital transformation journey and the role of customer reference dataBetter management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Share XPharma’s digital transformation journey and the role of customer reference datahttps://pharmaphorum.com/views-analysis-digital/pharmas-digital-transformation-journey-and-the-role-of-customer-reference-data/
Takeda to partner on patient-centric data with SeqsterTakeda has partnered with patient data firm Seqster in a drive to improve care through better access and Share XTakeda to partner on patient-centric data with Seqsterhttps://pharmaphorum.com/news/takeda-to-partner-on-patient-centric-data-with-seqster/
Why 72% of patients don’t feel listened to by pharmaClaus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks Share XWhy 72% of patients don’t feel listened to by pharmahttps://pharmaphorum.com/views-analysis-patients/why-72-of-patients-dont-feel-listened-to-by-pharma/
What can we learn from women’s health data?Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Share XWhat can we learn from women’s health data?https://pharmaphorum.com/views-analysis-digital/what-can-we-learn-from-womens-health-data/
Data hackathon analyses truth behind TB vaccine and COVID-19Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet Share XData hackathon analyses truth behind TB vaccine and COVID-19https://pharmaphorum.com/r-d/views-analysis-r-d/data-hackathon-analyses-truth-behind-tb-vaccine-and-covid19/
How real human experiences can power a healthier futureAs part of our series of opinion pieces from leaders at Janssen, Maria Raad looks at how we Share XHow real human experiences can power a healthier futurehttps://pharmaphorum.com/views-analysis-digital/how-real-human-experiences-can-power-a-healthier-future/
